Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 949-231-7 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Genetic toxicity: in vitro
Administrative data
- Endpoint:
- in vitro gene mutation study in bacteria
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2019
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 019
- Report date:
- 2019
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 471 (Bacterial Reverse Mutation Assay)
- GLP compliance:
- yes (incl. QA statement)
- Type of assay:
- bacterial reverse mutation assay
Test material
- Reference substance name:
- 1-(1-oxododecyl)-L-proline
- Cas Number:
- 58725-39-6
- Molecular formula:
- C17H31NO3
- IUPAC Name:
- 1-(1-oxododecyl)-L-proline
- Reference substance name:
- 1-(1-oxotetradecyl)-L-Proline
- Cas Number:
- 86282-96-4
- Molecular formula:
- C19H35NO3
- IUPAC Name:
- 1-(1-oxotetradecyl)-L-Proline
- Reference substance name:
- 1-(1-oxodecyl)-L-Proline
- Cas Number:
- 86282-95-3
- Molecular formula:
- C15H27NO3
- IUPAC Name:
- 1-(1-oxodecyl)-L-Proline
- Reference substance name:
- 1-(1-oxooctyl)-L-Proline
- Cas Number:
- 86282-94-2
- Molecular formula:
- C13H23NO3
- IUPAC Name:
- 1-(1-oxooctyl)-L-Proline
- Reference substance name:
- 1(1-oxohexadecyl)-L-proline
- Cas Number:
- 59441-32-6
- Molecular formula:
- C21H39NO3
- IUPAC Name:
- 1(1-oxohexadecyl)-L-proline
- Reference substance name:
- Dodecanoylprolyl-Lproline
- IUPAC Name:
- Dodecanoylprolyl-Lproline
- Reference substance name:
- Tetradecanoylprolyl-L-proline
- IUPAC Name:
- Tetradecanoylprolyl-L-proline
- Reference substance name:
- Palmitoylprolyl-L-proline
- IUPAC Name:
- Palmitoylprolyl-L-proline
- Reference substance name:
- 1-(1-oxooctadecyl)-L-proline
- Molecular formula:
- C23H43NO3
- IUPAC Name:
- 1-(1-oxooctadecyl)-L-proline
- Reference substance name:
- potassium;chloride
- Cas Number:
- 7447-40-7
- Molecular formula:
- KCl
- IUPAC Name:
- potassium;chloride
- Reference substance name:
- Reference substance 001
- Cas Number:
- 1310-58-3
- Molecular formula:
- KOH
- Reference substance name:
- Tripotassium phosphate
- Cas Number:
- 7778-53-2
- IUPAC Name:
- Tripotassium phosphate
- Reference substance name:
- Unknown impurities
- IUPAC Name:
- Unknown impurities
Constituent 1
Constituent 2
Constituent 3
Constituent 4
Constituent 5
Constituent 6
Constituent 7
Constituent 8
Constituent 9
Constituent 10
Constituent 11
Constituent 12
impurity 1
Method
Species / strain
- Species / strain / cell type:
- S. typhimurium TA 1535, TA 1537, TA 98, TA 100 and TA 102
- Metabolic activation:
- with and without
- Test concentrations with justification for top dose:
- In two independent experiments several concentrations of the test item were used. Each assay was conducted with and without metabolic activation. The concentrations, including the controls, were tested in triplicate. The following concentrations of the test item were prepared and used in the experiments:
Experiment I:
3.16, 10.0, 31.6, 100, 316, 1000, 2500 and 5000 μg/plate
Experiment II:
1.0, 3.16, 10.0, 31.6, 100, 316, 1000, 2500 and 5000 μg/plate
No precipitation of the test item was observed in any tester strain used in experiment I and II (with and without metabolic activation). - Vehicle / solvent:
- Distilled water
Controls
- Negative solvent / vehicle controls:
- yes
- Remarks:
- Vehicle control
- Positive controls:
- yes
- Positive control substance:
- sodium azide
- methylmethanesulfonate
- other: 2-aminoanthracene - with metabolic activation 4-NOPD; 4-nitro-o-phenylene-diamine - without metabolic activation
- Details on test system and experimental conditions:
- Pre-Experiment for Toxicity
The toxicity of the test item was determined with tester strains TA98 and TA100 in a pre-experiment. Eight concentrations were tested for toxicity and induction of mutations with three plates each. The experimental conditions in this pre-experiment were the same as described below for the main experiment I (plate incorporation test).
Toxicity may be detected by a clearing or rather diminution of the background lawn or a reduction in the number of revertants down to a mutation factor of approximately ≤ 0.5 in relation to the solvent control.
The test item was tested in the pre-experiment with the following concentrations:
3.16, 10.0, 31.6, 100, 316, 1000, 2500 and 5000 μg/plate
Exposure Concentrations
The test item concentrations to be applied in the main experiments were chosen according to the results of the pre-experiment (see chapter 12.1.1 Pre-Experiment). 5000 μg/plate was selected as the maximum concentration. The concentration range covered two logarithmic decades. Two independent experiments were performed with the following concentrations:
Experiment I:
3.16, 10.0, 31.6, 100, 316, 1000, 2500 and 5000 μg/plate
Experiment II:
1.0, 3.16, 10.0, 31.6, 100, 316, 1000, 2500 and 5000 μg/plate
As the results of the pre-experiment were in accordance with the criteria described above, these were reported as a part of the main experiment I.
Experimental Performance
For the plate incorporation method the following materials were mixed in a test tube and poured over the surface of a minimal agar plate:
100 μL Test solution at each dose level, solvent control, negative control or reference mutagen solution (positive control),
500 μL S9 mix (for testing with metabolic activation) or S9 mix substitution buffer (for testing without metabolic activation),
100 μL Bacteria suspension (cf. Preparation of Bacteria, pre-culture of the strain),
2000 μL Overlay agar.
For the pre-incubation method 100 μL of the test item preparation was pre-incubated with the tester strains (100 μL) and sterile buffer or the metabolic activation system (500 μL) for 60 min at 37 °C prior to adding the overlay agar (2000 μL) and pouring onto the surface of a minimal agar plate.
For each strain and dose level, including the controls, three plates were used.
After solidification the plates were inverted and incubated at 37 °C for at least 48 h in the dark.
Evaluation of Cytotoxicity
Cytotoxicity can be detected by a clearing or rather diminution of the background lawn (indicated as "N" or "B", respectively in the result tables) or a reduction in the number of revertants down to a mutation factor of approximately ≤ 0.5 in relation to the solvent control.
10.8. Criteria of Validity
A test is considered acceptable if for each strain:
- the bacteria demonstrate their typical responses to ampicillin (TA98, TA100, TA102)
- the negative control plates (A. dest.) with and without S9 mix are within the ranges (mean values of the spontaneous reversion frequency within the historical control data range (2016 -2018))
- corresponding background growth on negative control, solvent control and test plates is observed
- the positive controls show a distinct enhancement of revertant rates over the control plate
- at least five different concentrations of each tester strain are analysable.
Evaluation of Mutagenicity
The Mutation Factor is calculated by dividing the mean value of the revertant counts by the mean values of the solvent control (the exact and not the rounded values are used for calculation).
A test item is considered as mutagenic if:
- a clear and dose-related increase in the number of revertants occurs and/or
- a biologically relevant positive response for at least one of the dose groups occurs
in at least one tester strain with or without metabolic activation.
A biologically relevant increase is described as follows:
- if in tester strains TA98, TA100 and TA102 the number of reversions is at least twice as high
- if in tester strains TA1535 and TA1537 the number of reversions is at least three times higher
than the reversion rate of the solvent control.
According to OECD guidelines, the biological relevance of the results is the criterion for the interpretation of results, a statistical evaluation of the results is not regarded as necessary.
A test item producing neither a dose related increase in the number of revertants nor a reproducible biologically relevant positive response at any of the dose groups is considered to be non-mutagenic in this system.
Results and discussion
Test resultsopen allclose all
- Key result
- Species / strain:
- S. typhimurium TA 98
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Remarks:
- at concentrations of 1000 μg/plate and higher (with and without metabolic activation)
- Vehicle controls validity:
- valid
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 100
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Remarks:
- In experiment I, toxicity at concentrations of 1000 μg/plate and higher (with and without metabolic act.). In experiment II, toxicity at 1000 μg/plate and higher (without metabolic act.) and at 2500 μg/plate and higher (with metabolic act.).
- Vehicle controls validity:
- valid
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 102
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Remarks:
- In tester strain TA102 toxic effects of the test item were observed at concentrations of 1000 μg/plate and higher (without metabolic activation).
- Vehicle controls validity:
- valid
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 1537
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Remarks:
- In experiment I, toxicity at concentrations of 2500 μg/plate and higher (without metabolic act.). In experiment II, toxicity was noted at 100 μg/plate and higher (without metabolic act.) and at 1000 μg/plate and higher (with metabolic act.).
- Vehicle controls validity:
- valid
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 1535
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Remarks:
- In experiment I, toxicity at concentrations of 1000 μg/plate and higher (with and without metabolic act.). In experiment II, toxicity was noted at 100 μg/plate and higher (without metabolic act.) and at 1000 μg/plate and higher (with metabolic act.).
- Vehicle controls validity:
- valid
- Positive controls validity:
- valid
- Additional information on results:
- The test item Cocoyl Proline CAS 960241-19-4 was investigated for its potential to induce gene mutations according to the plate incorporation test (experiment I) and the pre-incubation test (experiment II) using Salmonella typhimurium strains TA98, TA100, TA1535, TA1537 and TA102.
In two independent experiments several concentrations of the test item were used. Each assay was conducted with and without metabolic activation. The concentrations, including the controls, were tested in triplicate.
The following concentrations of the test item were prepared and used in the experiments:
Experiment I:
3.16, 10.0, 31.6, 100, 316, 1000, 2500 and 5000 μg/plate
Experiment II:
1.0, 3.16, 10.0, 31.6, 100, 316, 1000, 2500 and 5000 μg/plate
No precipitation of the test item was observed in any tester strain used in experiment I and II (with and without metabolic activation).
Toxic effects of the test item were noted in most tester strains evaluated in experiment I and II.
In experiment I toxic effects of the test item were observed in tester strains TA98, TA100 and TA1535 at concentrations of 1000 μg/plate and higher (with and without metabolic activation). In tester strain TA1537 toxic effects of the test item were noted at concentrations of 2500 μg/plate and higher (without metabolic activation).
In experiment II toxic effects of the test item were noted in tester strain TA98 at concentrations of 1000 μg/plate and higher (without and with metabolic activation). In tester strain TA100 toxic effects were noted at concentrations of 1000 μg/plate and higher (without metabolic activation) and at concentrations of 2500 μg/plate and higher (with metabolic activation). In tester strains TA1535 and TA1537 toxic effects of the test item were noted at concentrations of 100 μg/plate and higher (without metabolic activation) and at concentrations of 1000 μg/plate and higher (with metabolic activation). In tester strain TA102 toxic effects of the test item were observed at concentrations of 1000 μg/plate and higher (without metabolic activation). The reduction in the number of revertants down to a mutation factor of ≤ 0.5 found in tester strain TA1535 at a concentration of 31.6 μg/plate (with metabolic activation) was regarded as not biologically relevant due to lack of a dose-response relationship.
No biologically relevant increases in revertant colony numbers of any of the five tester strains were observed following treatment with Cocoyl Proline CAS 960241-19-4 at any concentration level, neither in the presence nor absence of metabolic activation in experiment I and II.
All criteria of validity were met. The reference mutagens induced a distinct increase of revertant colonies indicating the validity of the experiments. Only in experiment II, in tester strain TA1535 (with metabolic activation) a low mutation factor was found (2.2). Nevertheless, compared to the mutation factors found with the test item concentrations the increase can be considered as distinct. Thus, this effect was regarded as not biologically relevant.
Applicant's summary and conclusion
- Conclusions:
- In conclusion, it can be stated that during the described mutagenicity test and under the experimental conditions reported, Cocoyl Proline CAS 960241-19-4 did not cause gene mutations by base pair changes or frameshifts in the genome of the tester strains used.
Therefore, Cocoyl Proline CAS 960241-19-4 is considered to be non-mutagenic in this bacterial reverse mutation assay.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
